Published on 09/12/2025

Reference Data & Lookups: Governance That Sticks

In the pharmaceutical industry, particularly in the domains of biological and biopharmaceutical products, the management and governance of data is paramount. The reliance on computer systems, cloud services, and software applications necessitates stringent validation processes to ensure compliance with regulatory requirements. This article provides a detailed overview of the essential components of computer software assurance (CSA) and computer system validation (CSV) specifically within the context of cloud and Software as a Service (SaaS) environments. The focus will be on report and spreadsheet validation controls, data governance, and ensuring data integrity through best practices.

Understanding the Framework of Computer Software Assurance and Validation

Computer software assurance and validation are cornerstone activities within the regulated pharmaceutical sector. The goal of CSA/CSV is to ensure that software systems used in the development and manufacturing of biopharmaceuticals operate reliably and consistently. The primary regulations guiding these practices include 21 CFR Part 11, which delineates the criteria under which electronic records and signatures are considered trustworthy, reliable, and equivalent to paper records. In the EU, this is echoed in Annex 11 of the EU GMP guidelines.

When embarking on a software validation endeavor, stakeholders should consider the following critical areas:

• Intended Use & Risk Assessment: The first step in the validation process is to define the intended use of the software and assess its potential risks. Understanding how the software will be utilized and the implications for product quality is crucial.
• Configuration and Change Control: Effective configuration management and change control practices are necessary to manage updates and modifications to the software. This includes establishing a formal process for documenting changes, assessing impact, and ensuring traceability.
• Backups and Disaster Recovery Testing: Regular backups and a robust disaster recovery plan are crucial for maintaining data integrity and availability. Testing these plans will ensure that data can be restored in a timely manner in the event of a system failure.

Conducting Report and Spreadsheet Validation

Report validation and spreadsheet controls are critical in ensuring that the data generated by software applications are accurate, complete, and compliant with regulatory guidelines. GxP regulations, including those stipulated by the FDA and EMA, require that any system generating regulatory data must be validated. This includes spreadsheets often employed in various data analysis phases within biopharmaceuticals.

Here are essential steps involved in the report and spreadsheet validation process:

Step 1: Establish a Validation Plan

The validation plan serves as the blueprint for the validation process. It should outline:

• The purpose of the validation.
• The specific software and versions being validated.
• The scope of validation, including in-scope reports and spreadsheets.
• The resources required, including any team members and tools involved.

Step 2: User Requirements Specification (URS)

A comprehensive URS must be developed to reflect user needs and expectations. This document should cover functional requirements, performance criteria, and regulatory compliance aspects that the software must meet.

Step 3: System Design Specification (SDS)

The SDS translates user requirements into system-specific specifications. This document lays out how the software will fulfill the requirements outlined in the URS and is essential for guiding subsequent validation steps.

Step 4: Installation Qualification (IQ)

Installation Qualification is the validation phase where the system is verified against the installation specifications outlined in the SDS. This includes checking hardware, software, and any configuration settings to ensure they match the system specifications.

Step 5: Operational Qualification (OQ)

This phase tests the software system’s functionality to ensure that it operates according to the defined specifications in a controlled manner. During OQ, various functionalities are exercised to demonstrate that the software behaves as expected under normal operating conditions.

Step 6: Performance Qualification (PQ)

The final stage, Performance Qualification, confirms that the system consistently performs as intended in a user environment. This involves executing test scripts that mimic actual usage scenarios, ensuring that all output from reports and spreadsheets is accurate, compliant, and traceable.

Audit Trail Review in Software Validation

Audit trails are an integral part of software validation as they provide a chronological record of all changes made in the system. The importance of audit trails cannot be overstated in environments governed by stringent regulatory compliance.

Key aspects of audit trail review include:

• Implementation: Ensure the software has audit trail functionality enabled. This includes tracking changes, modifications, and user actions.
• Review Protocol: Define a protocol for routine audit trail reviews. This should include a frequency at which audits will be conducted, who will be responsible, and the scope of the review.
• Discrepancy Investigation: Establish clear procedures for investigating discrepancies identified during audit trail reviews. Include corrective and preventive actions to address any deviations from expected performance.

Data Retention and Archive Integrity

Data retention policies are vital for compliance with regulatory requirements, ensuring that data is stored securely and maintained for the appropriate duration. In light of 21 CFR Part 11 and related regulations, organizations must develop solid archiving strategies to protect the integrity of electronic records.

Key considerations for data retention and archiving include:

Establishing Retention Policies

Data retention policies must adhere to regulations and organizational needs. Considerations should include:

• The duration for which records must be retained, as informed by regulatory bodies.
• Strategies for ensuring the integrity and authenticity of data throughout the retention period.
• Criteria for safe and secure data disposal once retention periods have expired.

Implementing Archive Integrity Checks

Regular checks should be conducted to confirm the integrity of archived data. These checks should ensure that:

• The archived data can be accessed and retrieved when needed.
• All records maintain compliance with the applicable regulatory standards.
• Backups are performed frequently and are recoverable in case of data loss.

Continuous Improvement and Compliance Monitoring

As the biopharmaceutical landscape evolves, continuous improvement efforts must be integrated into the CSA/CSV processes. Compliance monitoring must remain dynamic, with organizations adapting to new technologies and regulatory updates.

Strategies for achieving continuous improvement include:

• Conducting periodic reviews of validation documentation to ensure relevance and accuracy.
• Implementing training programs for personnel involved in software validation and data management.
• Monitoring advancements in regulatory guidelines, such as those from the FDA and EMA, to ensure ongoing compliance.

Conclusion

In conclusion, the efficacy of biopharmaceutical development heavily relies on diligent data governance and validation practices. By implementing robust software validation processes, organizations can ensure compliance with regulations while maintaining the integrity of their data. This step-by-step approach provides a comprehensive framework for professionals involved in computer software assurance, enabling them to manage risks associated with software systems effectively. By adhering to validated procedures, pharmaceutical organizations can improve their operational efficiency and maintain regulatory compliance.